Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
toxoplasmosis
MeSH D014123 - toxoplasmosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003048:
Coccidiosis
0 Companies
0 Drugs
Success rate
D014123:
Toxoplasmosis
69 Companies
11 Drugs
$
Success rate
D014124:
Animal toxoplasmosis
0 Companies
0 Drugs
Success rate
D014125:
Congenital toxoplasmosis
0 Companies
0 Drugs
Success rate
D014126:
Ocular toxoplasmosis
0 Companies
0 Drugs
Success rate
D016781:
Cerebral toxoplasmosis
10 Companies
2 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Teva
Pyrimethamine
Pyrimethamine
2021-08-13
Roche
Pyrimethamine
,
Sulfadoxine
Fansidar
1982-01-01
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
75
%
3/4
Phase 2
0
%
0/0
Phase 3
100
%
5/5
Approved:
5
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Clindamycin
Padagis
Benzoyl peroxide
,
Clindamycin
Taro Pharmaceutical
Benzoyl peroxide
,
Clindamycin
Glenmark Pharmaceuticals
Benzoyl peroxide
,
Clindamycin
Mylan
Benzoyl peroxide
Roche
Sulfamethoxazole
,
Trimethoprim
Bausch Health Companies
Adapalene
,
Benzoyl peroxide
,
Clindamycin
,
Polymyxin b
,
Tretinoin
,
Trimethoprim
Allergan
Benzoyl peroxide
,
Clindamycin
,
Tretinoin
Pfizer
Clindamycin
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use